REQUEST A DEMO
Total
USD $0.00
Search more companies

Domi Farmacja M. Klups, D. Ziebaczewski sp. j. (Poland)

Main Activities: Department Stores
Secondary Activities: Pharmacies and Drug Stores | All Other Support Services
Full name: Domi Farmacja M. Klups, D. Ziebaczewski sp. j. Profile Updated: April 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Domi Farmacja M. Klups, D. Ziebaczewski sp. j. is a company based in Poland, with its head office in Warsaw. It operates in the Department Stores sector. The company was established on February 06, 2020. From the latest financial highlights, Domi Farmacja M. Klups, D. Ziebaczewski sp. j. reported a net sales revenue increase of 15.11% in 2024. During that time, Domi Farmacja M. Klups, D. Ziebaczewski sp. j.’s total assets grew by 1.47%. The net profit margin of Domi Farmacja M. Klups, D. Ziebaczewski sp. j. increased by 2.33% in 2024.

Headquarters
Ul. Plac Bankowy 2
Warsaw; Mazowieckie; Postal Code: 00-095

Contact Details: Purchase the Domi Farmacja M. Klups, D. Ziebaczewski sp. j. report to view the information.

Basic Information
Financial Auditors:
Purchase the Domi Farmacja M. Klups, D. Ziebaczewski sp. j. report to view the information.
Incorporation Date:
February 06, 2020
Key Executives
Purchase this report to view the information.
Associate
Purchase this report to view the information.
Associate
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Domi Farmacja M. Klups, D. Ziebaczewski sp. j. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
15.11%
Total operating revenue
15.23%
Operating profit (EBIT)
228.55%
EBITDA
105.96%
Net Profit (Loss) for the Period
15.65%
Total Assets
1.47%
Total Equity
-14.38%
Operating Profit Margin (ROS)
0.87%
Net Profit Margin
2.33%
Return on Equity (ROE)
-4.48%
Debt/Equity
80.35%
Quick Ratio
0.6%
Cash Ratio
0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?